JoVE Logo

Accedi

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.

A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of thiosulfate occurs through the transamination of β-cysteine to mercaptopyruvate.

Another significant phase II reaction involves conjugating endogenous purine and pyrimidine bases with ribose to create nucleotides. These nucleotides play a crucial role in protein synthesis and energy metabolism, highlighting the importance of this biotransformation process.

Finally, taurine, a β-amino sulphonic acid, contributes significantly to bile production. It conjugates with endogenous bile acids, adding to the composition of bile, which plays a pivotal role in digestion.

Phase II conjugation reactions neutralize harmful substances, support essential biological processes, and contribute to digestive functions, demonstrating their importance in maintaining overall health.

Tags

Phase II ReactionsBiotransformationsDetoxificationXenobioticsConjugationCyanide IonCellular RespirationRhodaneseThiosulfateThiocyanateNucleotidesProtein SynthesisEnergy MetabolismTaurineBile ProductionDigestion

Dal capitolo 5:

article

Now Playing

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

33 Visualizzazioni

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

228 Visualizzazioni

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

216 Visualizzazioni

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

125 Visualizzazioni

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

51 Visualizzazioni

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

166 Visualizzazioni

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

55 Visualizzazioni

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

131 Visualizzazioni

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

194 Visualizzazioni

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

141 Visualizzazioni

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

121 Visualizzazioni

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

146 Visualizzazioni

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

104 Visualizzazioni

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

138 Visualizzazioni

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

88 Visualizzazioni

JoVE Logo

Riservatezza

Condizioni di utilizzo

Politiche

Ricerca

Didattica

CHI SIAMO

Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati